Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.57CHF
13.34 BCHF
40.83 BCHF
1.75 B
About NOVARTIS N
Sector
CEO
Vasant Narasimhan
Headquarters
Basel
Website
Employees (FY)
76.06 K
Founded
1996
ISIN
CH0012005267
FIGI
BBG000RGZJL1
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where NOVNZ is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange NOVARTIS AG-REG stocks are traded under the ticker NOVNZ.
We've gathered analysts' opinions on NOVARTIS AG-REG future price: according to them, NOVNZ price has a max estimate of 119.62 CHF and a min estimate of 75.72 CHF. Watch NOVNZ chart and read a more detailed NOVARTIS AG-REG stock forecast: see what analysts think of NOVARTIS AG-REG and suggest that you do with its stocks.
NOVNZ reached its all-time high on Jul 20, 2015 with the price of 103.10 CHF, and its all-time low was 48.36 CHF and was reached on May 18, 2012. View more price dynamics on NOVNZ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track NOVARTIS AG-REG financials in yearly and quarterly reports right on TradingView.
NOVARTIS AG-REG is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.
NOVNZ earnings for the last quarter are 1.62 CHF per share, whereas the estimation was 1.51 CHF resulting in a 7.29% surprise. The estimated earnings for the next quarter are 1.63 CHF per share. See more details about NOVARTIS AG-REG earnings.
NOVARTIS AG-REG revenue for the last quarter amounts to 10.67 B CHF, despite the estimated figure of 10.32 B CHF. In the next quarter, revenue is expected to reach 11.07 B CHF.
NOVNZ net income for the last quarter is 2.35 B CHF, while the quarter before that showed 7.52 B CHF of net income which accounts for −68.76% change. Track more NOVARTIS AG-REG financial stats to get the full picture.
Yes, NOVNZ dividends are paid annually. The last dividend per share was 3.30 CHF. As of today, Dividend Yield (TTM)% is 3.46%. Tracking NOVARTIS AG-REG dividends might help you take more informed decisions.
NOVARTIS AG-REG dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 29, 2024, the company has 76.06 K employees. See our rating of the largest employees — is NOVARTIS AG-REG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG-REG EBITDA is 18.76 B CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS AG-REG financial statements.
Like other stocks, NOVNZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG-REG stock right from TradingView charts — choose your broker and connect to your account.